A breast cancer gene (BRCA) mutation increases the risk of breast, ovarian, pancreatic, and prostate cancer.1 Talking about BRCA can be difficult, but it is important. https://learn.az/6182ACugG Start a conversation about BRCA today. #ThinkTalkTest #BRCA | AstraZeneca

We’re changing the future of BRCA research and care by sharing the facts. 1 in 40 individuals of Ashkenazi Jewish (Central or Eastern European) ancestry carry a BRCA gene mutation. This is 5x higher than the general population. Individuals of Ashkenazi Jewish ancestry at highest risk for carrying a BRCA mutation include those with: Breast cancer at age 65 or younger Triple negative breast cancer at any age Ovarian or fallopian tube cancer at any age More than one breast cancer diagnosis Male bre

BRCA-P | Breast Cancer Trials

BRCA Testing Saves Lives From Cancer—But Do You Need It?

Whether a BRCA Mutation Leads to Cancer Depends on Context, Study Finds

What Is BRCA Gene Mutation? When And Who Should Get Tested For It?

Everything You Need to Know about BRCA gene faults | Hereditary Cancer and Ovarian Cancer Risk

BRCA-P is a world-first trial that aims to prevent breast cancer in women with a BRCA1 gene mutation. At least one in 400 women in the developed world carries the hereditary BRCA1 gene mutation. This mutation is associated with approximately 70% risk of developing breast cancer and 40% risk of developing ovarian cancer, over the course of a lifetime. The current risk management for BRCA1 mutation carriers is limited to regular surveillance (MRI, mammogram, ultrasound, breast examination) or to h